Roche Holding AG Basel American Depositary Shares (RHHBY)

$41.46 0.82 (1.94%)

11:49 EDT RHHBY Stock Quote Delayed 30 Minutes

7 European Stocks to Buy to Diversify Your Portfolio

By Josh Enomoto, InvestorPlace Contributor Nov 4, 2021

While exposure to U.S.-based securities continues to be a good idea, you can diversify your opportunities by considering European stocks.

15 European Dividend Aristocrats to Diversify Your Portfolio

Roche Stock Rallies on Promising Coronavirus Drug Results

Roche Holding News: RHHBY Stock Jumps 8% on Faster Coronavirus Test

Volume:

Previous Close -

Market Cap -

PE Ratio -

EPS -

Volume (Avg. Vol.) 449,927

Day's Range $41.11 - $42.07

52-Week Range $37.88 - $53.86

Dividend & Yield N/A (N/A)

RHHBY Stock Predictions, Articles, and Roche Holding AG Basel American Depositary Shares News

From InvestorPlace
From the Web

7 Stocks to Buy From the T. Rowe Price Health Sciences Fund

By Will Ashworth, InvestorPlace Contributor May 6, 2019

One of the best mutual funds last year was the T. Rowe Price Health Sciences Fund. Here are 7 healthcare stocks to buy from its holdings.

3 Emerging Technologies Set to Transform the Pharma World

By Zacks Investment Research Apr 5, 2018

Here we discuss three emerging technologies, which the pharma/biotech industry has started adopting, albeit slowly. These are poised to transform the sector by....

Why NewLink Genetics Corp (NLNK), Urban Outfitters, Inc. (URBN) and Dell Technologies Inc (DVMT) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer Jun 8, 2017

Dell Technologies (DVMT), NewLink Genetics (NLNK) and Urban Outfitters (URBN) shareholders couldn't wait for Thursday's action to come to a close.

3 Cheap Biotech Stocks The Big Boys Are Buying (BLRX, OMED, FWP)

By Street Authority May 15, 2017

Biotechnology is among the most exciting and lucrative sectors for investors, and these 3 biotech stocks stand out...

iShares MSCI EAFE Index Fund (ETF) (EFA): The Quick Guide to EFA

By Todd Shriber, InvestorPlace Contributor May 8, 2017

The iShares MSCI EAFE ETF (EFA) holds nearly 940 stocks based outside the U.S. Is the EFA the right way to get international exposure?

Here’s How You Can Invest In The World’s Most Innovative Country: Switzerland (EWL)

By Street Authority Mar 20, 2017

I've uncovered a data set that show Switzerland as the most innovative country in the world. Here's how to take advantage...

Roche Holding Ltd. (ADR) (RHHBY) Stock Is Weathering the Healthcare Storm

By Richard Band Mar 16, 2017

Roche has plenty of great drugs under its umbrella and RHHBY stock should do well no matter what the government decides to do.

3 Bulletproof Income ETFs for 2017

By Contrarian Outlook Feb 1, 2017

Analysts are divided on if they think this bull market can last, but agree its a bumpy ride. Smooth it over with these ETF plays

Roche Holding Ltd. (RHHBY) Still Has a Few Tricks Up its Sleeve

By Richard Band Dec 22, 2016

The Big Pharma is set to have a very good 2017 and put 2016 behind it.

How Big Data & Big Pharma Will Transform Drug Development

By Brian Nichols, InvestorPlace Contributor Oct 12, 2015

Big data can be used by big pharma companies like Roche to drastically cut costs, increase drug production and drive long-term stock gains.

U.S. Debut of Biosimilar Drugs Threatens Major Biotechs

By Craig Adeyanju, InvestorPlace Contributor Sep 4, 2015

The introduction of biosimilar drugs will change the biotech landscape ... especially for these three names.

10 Healthcare Stocks Taking Aim at Cancer

By James Brumley, InvestorPlace Feature Writer May 8, 2015

Amgen, Inc. (NASDAQ:AMGN), Celgene Corporation (NASDAQ:CELG), Inovio Pharmaceuticals Inc. (NASDAQ:INO) and several other healthcare stocks are cancer medicine plays worth a look.

Add Roche to Your List of Ebola Stocks, But …

By James Brumley, InvestorPlace Feature Writer Dec 29, 2014

Ebola stocks have doled out some big gains to savvy traders this year, but investors looking for Roche (RHHBY) to do the same may want to rethink their expectations.

Gilead Stock Will Rise on Sovaldi® Sales

By Kenneth Fick, InvestorPlace Contributor Oct 24, 2014

Gilead's breakthrough Hepatitis C drug, Sovaldi®, will drive revenue and profits for the rest of 2014 and into 2015.

Roche Proves You Can’t Judge a Book by Its Cover

By James Brumley, InvestorPlace Feature Writer Sep 30, 2014

Roche stock may not be an NYSE or NASDAQ-listed equity, but when you look at the details, RHHBY is plenty investment-worthy.

3 Huge Healthcare Trends Can Fatten Your Portfolio

By Traders Reserve Nov 8, 2013

Healthcare concerns in the U.S. are being addressed by companies in the industry. These 3 issues can lead investors to stock opportunities

Our Stock Earnings Rundown – HSY KMB DFS SHW LUV TMO AMGN

By Louis Navellier, Editor, Growth Investor Oct 28, 2013

A big week for earnings and dividend increases includes these 8 stocks in our portfolio.

Roche’s Breast Cancer Drug Approval Is Just the Beginning

By James Brumley, InvestorPlace Feature Writer Oct 1, 2013

It might have been dismissed as irrelevant by most investors, but Roche and its Perjeta could reshape the breast cancer drug landscape.

Study: New Bird Flu Resistant to Roche’s Tamiflu

By Christopher Freeburn, InvestorPlace Writer May 28, 2013

Physicians in China have noted that some patients with bird flu are not responding to treatment with Tamiflu, the only known drug used to fight the infection.